HongShan-backed GenAI startup DIP raises nearly $50m Series D funding

HongShan-backed GenAI startup DIP raises nearly $50m Series D funding

Photo by Zulfugar Karimov on Unsplash

12 December, 2025

Edited by: Joymitra Rai

biotech CDH Investments.Deep Intelligent Pharma (DIP)GenAI HongShan Capital Group (HSG)pharmaceutical Xin Ding Capital

Printed by Unregistered user on Tue, 03 Feb 2026 15:21:21 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Multinationals rush to snap up Chinese biotech assets amid drug licensing boom

Lack of venture builders may delay growth of longevity biotech in Asia

Read more from Greater China

Hongkong Land launches $6.4b Singapore commercial real estate private fund

HSG forms entities in China, SG to hold newly acquired Avelox antibiotics business